Montelukast Sodium
Product Images NDC 67046-468

5 FDA label images from Contract Pharmacy Services-pa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 67046-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Contract Pharmacy Services-pa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (84523f08 21ad 4c8b 8693 639ff113c965 01)

Figure-1 (84523f08 21ad 4c8b 8693 639ff113c965 01)
A line graph showing change in height (cm) over weeks on treatment comparing Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo groups. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows height change in cm, with Montelukast Sodium and Beclomethasone groups showing increasing height changes over time compared to placebo.*
FDA Label Image

Molecular Structure (84523f08 21ad 4c8b 8693 639ff113c965 02)

Molecular Structure (84523f08 21ad 4c8b 8693 639ff113c965 02)
Chemical structure of montelukast sodium showing the arrangement of atoms including sodium ion, chlorine, and various carbon rings, consistent with the active ingredient montelukast sodium used in the product by Contract Pharmacy Services-PA.*
FDA Label Image

Mean Percent Change From Baseline (84523f08 21ad 4c8b 8693 639ff113c965 03)

Mean Percent Change From Baseline (84523f08 21ad 4c8b 8693 639ff113c965 03)
A line graph comparing mean percent change from baseline over 15 weeks in a treatment study. The x-axis represents weeks in treatment, while the y-axis shows mean percent change. Two data series are shown: placebo (open squares) and montelukast sodium (filled circles). Montelukast sodium shows a higher increase in mean percent change compared to placebo during the treatment period, with a decline during the washout phase after week 12.*
FDA Label Image

Company Logo (84523f08 21ad 4c8b 8693 639ff113c965 04)

FDA Label Image

Montelukast Sodium Tablets 10 mg (84523f08 21ad 4c8b 8693 639ff113c965 05)

Montelukast Sodium Tablets 10 mg (84523f08 21ad 4c8b 8693 639ff113c965 05)
Label for montelukast sodium 10 mg tablets, bottle of 30, labeled by Contract Pharmacy Services-PA. The label includes barcodes, lot number, pill ID, expiration date (05/17/18), storage instructions (20-25°C), and states each film-coated tablet contains montelukast sodium USP 10.4 mg equivalent to montelukast 10 mg. The NDC number 67046-468-30 is shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.